Back to search
Cold Agglutinin Disease (CAD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cold Agglutinin Disease (CAD) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cold Agglutinin Disease (CAD) trials you may qualify forThis is a multinational, multi-center, observational, prospective, longitudinal disease registry designed to collect data on participants with cold agglutinin d…
The purpose of the study is to determine the efficacy of pegcetacoplan administration compared to placebo in increasing hemoglobin (Hgb) level from baseline and…
The main purpose of this study was to evaluate the efficacy and safety of iptacopan in participants with autoimmune benign hematological disorders such as prima…
This was a multi-center, single treatment-group, open-label study to provide sutimlimab to the adult participants with cold agglutinin disease (CAD) who had com…
The goal of this clinical study is to evaluate povetacicept in adults with autoimmune cytopenias of immune thrombocytopenia, autoimmune hemolytic anemia, and co…
This study is to assess the safety, tolerability, preliminary efficacy, and pharmacokinetics of APL-2 in subjects with warm Autoimmune Hemolytic Anemia (wAIHA)…
Prospective, double-blind, randomized, placebo-controlled First-In-Human study with four sub-parts: Part A, a single ascending dose study (SAD) in normal human…